ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
-
Brussels to unveil 'EU Inc' pan-European company status
-
Iran to hold funeral for slain security chief as it vows vengeance
-
Greenland's teenage boxers throwing punches to survive
-
TotalEnergies faces ruling in Belgian farmer climate case
-
Brazil starts to restrict minors' access to social media
-
Trespasser caught in viral hippo Moo Deng's Thai zoo pen
-
Gilgeous-Alexander scores 40 as Thunder clinch playoff berth
-
Venezuela stun United States to win World Baseball Classic
-
Stocks extend gains and oil dips as US, Israel, Iran continue strikes
-
Iran missile fire kills two in central Israel: medics
-
Britain, Rwanda in £100m court clash over migrant deal
-
'We will wait for each one': Ukrainians greet POWs with tears and cheers
-
UN watchdog says projectile struck Iran nuclear power plant
-
Trump faces impasse over Iran war
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Former Australian Test wicketkeeper Haddin to coach NSW
-
China coach says team on right track despite Asian Cup heartache
-
Oscars audience drops, viewing figures show
-
Resilient Australia 'need to be better' in Women's Asian Cup final
-
Gio Reyna picked for US squad as Pochettino says World Cup roster still 'open'
-
Colombia, Ecuador leaders clash over bomb dropped near border
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 18
-
PSG, Real Madrid and Arsenal march into Champions League last eight
-
'Incomplete' Man City not what they once were, says Guardiola
-
US judge orders Trump admin to bring VOA employees back to work
-
White House pressure on Cuba mounts as island fights power cut
-
Arteta hails 'magical' Eze after Arsenal star sinks Leverkusen
-
Senegal stripped of AFCON title, Morocco declared champions
-
Nvidia says restarting production of China-bound chips
-
Panic as Israel army urges residents to evacuate south Lebanon's Tyre area
-
Real Madrid 'change' under Champions League spotlight: Vinicius
-
Real Madrid dump Man City out of Champions League once more
-
Clinical PSG bury Chelsea to reach Champions League quarter-finals
-
Eze rocket fires Arsenal into Champions League quarters
-
US airlines still see strong demand as jet fuel worries loom
-
Milei blasts Iran on anniversary of attack on Israeli embassy
-
USS Gerald R. Ford: the world's biggest aircraft carrier
-
US, European stocks rise despite latest jump in oil prices
-
Sporting Lisbon thrash Bodo/Glimt to reach Champions League quarters
-
Irish PM pushes Trump on Iran -- politely
-
Arizona charges prediction market Kalshi with illegal election betting
-
Leftist New York mayor under pressure on Irish unity question
-
Atletico boss Simeone defends Spurs star Romero
-
Iran vets friendly ships for Hormuz passage: trackers
-
Iran women's football team arrive in Turkey on way home
-
Mexico prepared to host Iran World Cup games, says president
-
Trump blasts 'foolish' NATO on Iran, says US needs no help
-
Slot vows to win back support of frustrated Liverpool fans
-
In Ukraine, Sean Penn gifted Oscar made from train carriage hit by Russia
-
Ships in Gulf risk shortages on board, industry warns
ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
NORTHVALE, NJ / ACCESS Newswire / February 13, 2026 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its third fiscal quarter ended December 31, 2025 of Fiscal Year 2026.
The upward trend in revenues, as reported in the Company's previous quarterly reports, continues for this third fiscal quarter of fiscal year ended March 31, 2026. For the nine months ended December 31, 2025 revenues increased 9% and 7% for the three months ended December 31, 2025, as compared to the same periods last fiscal year. Research and development activity and expense are continuing on the Company's proprietary non-invasive musculoskeletal pain therapy medical device. When engineering development is completed, the Company intends to submit a 510(k) Pre-Market Notification to the FDA for clearance to market.
Revenues for the three months ended December 31, 2025 were $803,088 as compared to $749,510 for the three months ended December 31, 2025, an increase of 8%. Loss from operations for the three months ended December 31, 2025 was $84,441 as compared to loss of $89,269 for the same period last year.
Revenues for the nine months ended December 31, 2025 were $2,664,2611 as compared to $2,447,391 for the nine months ended December 31, 2024, an increase of 9%. Income from operations for the nine months ended December 31, 2025 was $27,346 as compared to income of $29,154 for the same period last year.
Complete financial results are available in the Company's Quarterly Report on Form 10Q for December 31, 2025, available at www.sec.gov.
Financial Highlights
Three Months Ended | Nine Months Ended | |||||||||||
December 31, | December 31, | |||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||
Net Revenues | $ | 803,088 | $ | 749,510 | $ | 2,664,261 | $ | 2,447,391 | ||||
Cost of Sales | $ | 530,592 | $ | 481,331 | $ | 1,534,675 | $ | 1,239,527 | ||||
Gross Profit | $ | 272,496 | $ | 268,179 | $ | 1,129,586 | $ | 1,207,864 | ||||
Total Operating Expenses | $ | 356,937 | $ | 357,448 | $ | 1,102,240 | $ | 1,178,710 | ||||
Income (loss) from operations | $ | (84,441 | ) | $ | (89,269 | ) | $ | 27,346 | $ | 29,154 | ||
Total other income (expense) | $ | (30,415 | ) | $ | (142,500 | ) | $ | 72,260 | $ | (45,850 | ) | |
Income (loss) before provision for income taxes | $ | (114,856 | ) | $ | (237,177 | ) | $ | 99,606 | $ | (16,696 | ) | |
Total provision (benefit) for income taxes | - | $ | 500 | $ | 1,500 | $ | 1,500 | |||||
Net income (loss) | $ | (114,856 | ) | $ | (237,677 | ) | $ | 98,106 | $ | (18,196 | ) | |
Basic and diluted per common share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
Weighted average shares of common stock outstanding - basic and diluted | 67,588,492 | 67,588,492 | 67,588,492 | 67,588,492 | ||||||||
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered and ISO-13485 Certified medical device and manufacturing operations are located in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for the research, development and commercialization of diversified technologies. Additional information is available at admtronics.com
Sign up for ADMT Investor News Updates emails by filling in the form at the bottom of the page at this link: https://admtronics.com/investor-relations/
Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact Information:
Andre DiMino
+12017676040
[email protected]
SOURCE: ADM Tronics Unlimited Inc.
View the original press release on ACCESS Newswire
O.M.Souza--AMWN
